Concepedia
Statistics
Publications
109
Citations
6K
H-Index
42
Active since
1978
Affiliations
Leo Pharma (Denmark)(Current)
Uppsala University Hospital
Cedars-Sinai Medical Center
Leo Pharma (Australia)
St George's, University of London
Lise Binderup is an author at Leo Pharma (Denmark) specializing in medicine, pharmacology, and cell biology.
Top concepts
MedicinePharmacologyCell BiologyCancer ResearchTumor BiologyImmunologyOncologyTumor MicroenvironmentRadiation OncologyCancer Biology
Publications per year
1978–2006
Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo
Lise Binderup, E. Bramm · Biochemical Pharmacology · 1988 · 368 citations
Metabolic Bone Disease, Medicine, Clinical Nutrition +7
20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responses
Lise Binderup, Scilla Latini, Ernst Binderup et al. · Biochemical Pharmacology · 1991 · 321 citations
Inflammation, Cytokine, Autoimmune Disease +13
Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
G. Darío Díaz, Christos Paraskeva, M G Thomas et al. · PubMed · 2000 · 317 citations
Chemoprevention Strategy, Carcinoma Cells, Apoptosis +16
Inhibitory Effects of 1α,25-Dihydroxyvitamin D3 on the G1–S Phase-Controlling Machinery
Simon Skjøde Jensen, Mogens Winkel Madsen, Jiří Lukáš et al. · Molecular Endocrinology · 2001 · 229 citations · Full text
EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro
Kay W. Colston, Alan Mackay, Sharon Y. James et al. · Biochemical Pharmacology · 1992 · 225 citations
Tumor Biology, Breast Oncology, Medicine +9
1–5 of 109